Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 4/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28321853 | 1.00 | TSHR (0.46) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL9947943 | 1.00 | TSHR (0.46) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL1319101 | 1.00 | TSHR (0.46) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL28675357 | 1.00 | TSHR (0.46) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL1973138 | 1.00 | TSHR (0.46) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL28322816 | 1.00 | TSHR (0.46) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL9947731 | 0.98 | TSHR (0.44) | TSHRZDHHC7FAAHGPR84FFAR1 | |
| SCHEMBL5614779 | 0.94 | TSHR (0.41) | TSHRZDHHC7ALDH1A1CA2 | |
| SCHEMBL2839521 | 0.87 | ALDH1A1 (0.42) | TSHRALDH1A1 | |
| SCHEMBL4600145 | 0.87 | TSHR (0.45) | TSHRZDHHC7FAAHGPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315929-A1 | DENTAL ADHESIVE KIT | KURARAY NORITAKE DENTAL INC. (JP) | 2024-09-26 | — | — | US | disclosed |
| EP-4360609-A1 | DENTAL ADHESIVE KIT | Kuraray Noritake Dental Inc. (JP) | 2024-05-01 | — | — | EP | disclosed |
| WO-2022270601-A1 | DENTAL ADHESIVE KIT | クラレノリタケデンタル株式会社 | 2022-12-29 | — | — | WO | disclosed |
| US-10705261-B2 | Conductive coating liquid composition, and an antistatic film and a display device using the same | LG DISPLAY CO., LTD. (KR) | 2020-07-07 | — | — | US | disclosed |
| CN-110325167-A | Gear division curable composition | 株式会社GC | 2019-10-11 | — | — | CN | disclosed |
| US-10418147-B2 | Conductive coating liquid composition, and an antistatic film and a display device using the same | LG DISPLAY CO., LTD. (KR) | 2019-09-17 | — | — | US | disclosed |
| US-10144836-B2 | Carbon nanotube dispersion liquid composition and method for manufacturing of the same, conductive coating liquid composition comprising the samen, antistatic film and display device using the same | LG DISPLAY CO., LTD. (KR) | 2018-12-04 | — | — | US | disclosed |
| US-20170283625-A1 | CARBON NANOTUBE DISPERSION LIQUID COMPOSITION AND METHOD FOR MANUFACTURING OF THE SAME, CONDUCTIVE COATING LIQUID COMPOSITION COMPRISING THE SAMEN, ANTISTATIC FILM AND DISPLAY DEVICE USING THE SAME | NANO Solution CO.,LTD (KR) | 2017-10-05 | — | — | US | disclosed |
| US-9714350-B2 | Carbon nanotube dispersion liquid composition and method for manufacturing of the same, conductive coating liquid composition comprising the same, antistatic film and display device using the same | LG DISPLAY CO., LTD. (KR) | 2017-07-25 | — | — | US | disclosed |
| US-20170192134-A1 | CONDUCTIVE COATING LIQUID COMPOSITION, AND AN ANTISTATIC FILM AND A DISPLAY DEVICE USING THE SAME | NANO SOLUTION CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| WO-2007003513-A1 | PROCESS FOR THE PRODUCTION OF POROUS RETICULATED COMPOSITE MATERIALS | CINVENTION AG (DE) | 2007-01-11 | — | — | WO | disclosed |
| US-20070003749-A1 | Process for production of porous reticulated composite materials | CINVENTION AG (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070003753-A1 | Medical devices comprising a reticulated composite material | CINVENTION AG (DE) | 2007-01-04 | — | — | US | disclosed |
| WO-2006082221-A1 | DRUG DELIVERY MATERIALS MADE BY SOL/GEL TECHNOLOGY | CINVENTION AG (DE) | 2006-08-10 | — | — | WO | disclosed |
| US-20060171990-A1 | Drug delivery materials made by sol/gel technology | CINVENTION AG (DE) | 2006-08-03 | — | — | US | disclosed |
| US-20060167147-A1 | Metal-containing composite materials | BLUE MEMBRANES GMBH | 2006-07-27 | — | — | US | disclosed |
| WO-2006077256-A1 | METAL CONTAINING COMPOSITE MATERIALS | CINVENTION AG (DE) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006074809-A2 | COMPOSITE MATERIALS CONTAINING CARBON NANOPARTICLES | CINVENTION AG (DE) | 2006-07-20 | — | — | WO | disclosed |
| US-20060155376-A1 | Composite materials containing carbon nanoparticles | BLUE MEMBRANES GMBH | 2006-07-13 | — | — | US | disclosed |
| US-6849670-B2 | Photo-curable reparative material for dental use | TOKUYAMA CORPORATION (JP) | 2005-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240315929-A1 | DENTAL ADHESIVE KIT | ITGA1, CAD, ITGA2 | TSHR 4522/4885ZDHHC7 3557/4885FAAH 1779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.